Gujarat Kidney & Super Speciality came to market through an IPO that opened on 22 December 2025 and closed on 24 December 2025, and the shares listed on 30 December 2025 on BSE, NSE. The price band was ₹108 to ₹114 per share and one lot was 128 shares, so the minimum application was ₹14,592. The issue size was ₹250.8 crore. The whole issue was fresh shares, so the money raised went to the company.
MUFG Intime India Pvt.Ltd was the registrar to the issue, and Nirbhay Capital Services Pvt.Ltd was the lead manager.
As of 24 December 2025.
| Day |
|---|
| 1 |
| 2 |
| 3 |
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) is a multispecialty health care service provider engaged in the provision of secondary and tertiary health care services in multiple locations across Gujarat, India. At the close of business on March 20, 2025, it operates six multispeciality hospitals and three pharmacies, representing a total bed capacity of 400 beds with an approved capacity of 355 beds and an operational capacity of 250 beds.
The hospitals in the company include Gujarat Kidney and Super Speciality Hospital, Vadodara, Gujarat Multispeciality Hospital, Godhra, Raj Palmland Hospital Private Limited, Bharuch, M/s. Surya Hospital and ICU, Borsad, Gujarat Surgical Hospital, Vadodara, and Ashwini Medical Centre, Anand. It also holds a drugstore, Ashwini Medical Store, Anand. Services: Secondary Care Services: This refers to both general and surgical treatments. Tertiary Care Services: Super speciality surgical procedures.
Gujarat Superspeciality Hospital provides medical care in the field of internal medicine, general surgery, minimally invasive procedures, orthopaedics and trauma treatment, joint replacement surgery, obstetrics and gynaecology, respiratory failure, non-interventional cardiology, diabetology, and anaesthesiology. At March 20, 2025, the company had 322 employees, which include 21 full-time Consultants and 32 visiting consultants. At September 30, 2024, the healthcare professionals of the company comprised 47 doctors and 138 nurses.
As described in the offer document.
| Metric | 30-Jun-25 | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 |
|---|
Gujarat Kidney and Super Speciality rakes in more than Rs 100 crore through anchor book ahead of the IPO. Craft Emerging Market Fund, through its two sub funds viz. Citadel Capital Fund and Elite Capital Fund is the largest investor in the company's anchor book, subscribing 39.47 lakh shares at Rs 45 crore. This comes after Khandelwal Finance and Venus Investments picked 13.16 lakh shares for Rs 15 crore, and 8.77 lakh shares for Rs 10 crore, respectively.
Other investors in the anchor book included Nexus Global Opportunities Fund, Arnesta Global Opportunities Fund, Zeta Global Funds, Religo Commodities Ventures Trust, Sunrise Investment Trust, and Innovative Vision Fund, which bought 4.38 lakh shares each for Rs 5 crore in Gujarat Kidney.
Dr. Pragnesh Yashwantsinh Bharpoda, Dr. Bhartiben Pragnesh Bharpoda, Dr. Yashwantsingh Motisinh Bharpoda, Anitaben Yashwantsinh Bharpoda. Promoter holding 99.10% before the issue and 71.45% after.
Work out the listing gain for this IPO
If the retail portion is not fully subscribed, every valid application is allotted in full. If it is oversubscribed, SEBI's rules require that as many applicants as possible receive at least one lot, so the shares are allotted by a computerised lottery across all valid applications, one lot each, until the retail portion is exhausted. Applying for more lots does not improve your chance in a lottery; it only increases what you receive if the issue is under-subscribed.
The basis of allotment document, published by the registrar on the allotment date, states the ratio: for example, one applicant in seven received one lot.
Allotment status is published by the registrar on its website, searchable by PAN, application number or demat account, and also on the exchange's website. Allotted shares are credited to the demat account the day before listing, and blocked money for unsuccessful applications is released the same day. The Rupix app can check allotment status by PAN once the registrar publishes it.
Shares list within three working days of the issue closing. On listing day the exchanges run a special pre-open session from nine o'clock, during which orders are collected and an opening price is discovered from them; trading in the share begins after that, usually around ten. The opening price is the listing price that appears on this page once the issue has listed, and the listing gain or loss is the difference between it and the issue price.
For a mainboard issue, the share then trades in the normal way with the exchange's price band for a new listing. For an SME issue, shares trade in lots rather than one at a time, and the market can be thin, so selling on listing day is not always possible at the opening price. Capital gains on shares sold within a year of allotment are short-term and taxed at the short-term rate.
Gujarat Kidney & Super Speciality IPO was a ₹250.8 crore book-built issue, made up entirely of a fresh issue. It was priced at ₹108–₹114 per share with a lot size of 128 shares (₹14,592). The IPO was open from December 22 to December 24, 2025 and was subscribed 5.21x. Shares listed on BSE and NSE on December 30, 2025 at ₹120, a 5.3% premium to the issue price of ₹114. MUFG Intime India Pvt. Ltd. is the registrar.
Nirbhay Capital Services Pvt. Ltd. is the book running lead manager.
The price band of Gujarat Kidney & Super Speciality IPO is ₹108 to ₹114 per share.
The lot size of Gujarat Kidney & Super Speciality IPO is 128 shares.
The minimum investment for Gujarat Kidney & Super Speciality IPO is approximately ₹14,592 based on the upper price band.
The allotment date of Gujarat Kidney & Super Speciality IPO is Dec 26, 2025.
Gujarat Kidney & Super Speciality IPO listed on Dec 30, 2025. It was issued at ₹120.0(NSE) and is currently around ₹162.00 as on 2-Nov-2026 3:30 PM, which is approximately 42.1% versus issue price. The 52-week high is ₹209.80.
You can check Gujarat Kidney & Super Speciality IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Gujarat Kidney & Super Speciality IPO allotment status on Rupix for quick and easy access.
₹108 to ₹114 per share, against a face value of ₹2. Most applicants bid at the cut-off price, the top of the band, so that the application was valid whatever price the issuer finally fixed.
One lot was 128 shares, and every application had to be a whole number of lots. At the top of the band that made the minimum application ₹14,592.
₹14,592, for one lot of 128 shares at the top of the price band. The amount was blocked in the applicant's bank account through ASBA or a UPI mandate while the issue was open, and released on the allotment date to applicants who were not allotted shares.
It opened on 22 December 2025 and closed on 24 December 2025.
The basis of allotment was published on 26 December 2025 by MUFG Intime India Pvt.Ltd, and allotted shares were credited to demat accounts before listing.
The shares listed on 30 December 2025 on BSE, NSE.
The issue size was ₹250.8 crore. The fresh issue was 2,20,00,000 shares (aggregating up to ₹250.8 crore).